Development and Evaluation of a Life Review Program for Advanced Cancer Patients in Fuzhou, China
18 Years
N/A
Both
Advanced Cancer
Trial Information
Development and Evaluation of a Life Review Program for Advanced Cancer Patients in Fuzhou, China
A life review program is mainly developed based on Erickson's theory, Confucius's teaching
on human development, and the empirical findings of the researcher's preliminary study and
pre-pilot study. The program covers reviewing a life for advanced cancer patients and
formulating a booklet for them. A randomized controlled trial will be adopted for
evaluation of this program. Eligible patients will be randomly assigned to the experimental
group and the control group. The subjects in the experimental group will receive a life
review program for three weeks. The outcome measure is quality of life (QOL), including
domains of physical discomfort, food-related concerns, health care concerns, support,
negative emotions, sense of alienation, existential distress and value of life. Subjects'
QOL will be assessed before commencement of the program (T0) and one day (T1) and three
weeks (T2) after the completion of the program for all subjects in two groups. Perceptions
of the program will be elicited within three days after the program for subjects in the
experimental group.Descriptive statistics will be used to analyze patients' personal
information, disease related information, functional performance and QOL of advanced cancer
patients. Repeated measures ANOVA will be used to measure QOL differences in between-group,
within-group and interaction effects. Content analysis will be used to analyze the
qualitative data collected.
Inclusion Criteria:
1. Patients who are newly admitted to the study hospice
2. Patients who are suffering from cancer with metastasis made by a physician
3. Patients who know their diagnosis, prognosis and therapy
4. Patients' functional performance (the score of KPS) at or more than 50%
5. Patients who are adults (≥18 years old)
6. Patients who have no cognitive and verbal communication impairments
Exclusion Criteria:
1. Patients with planned treatments, such as chemotherapy, radiotherapy or surgery
2. , patients with psychiatric disorders
3. Patients who live outside Fuzhou since the following-up home visit services are not
extended to those areas
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Outcome Measure:
quality of life
Outcome Time Frame:
three weeks and six weeks
Safety Issue:
No
Principal Investigator
Enid Kwong, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
School of Nursing, The Hong Kong Polytechnic University
Authority:
China: Ethics Committee
Study ID:
HSEARS20090205002
NCT ID:
NCT00951262
Start Date:
February 2009
Completion Date:
August 2010
Related Keywords:
- Advanced Cancer
- life review
- quality of life
- advanced cancer patients
- Neoplasms
Name | Location |
|---|
